Retraction
Published on 26 Oct 2023
Retraction: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1301668
- 1,187 views
- Frontiers in Oncology
- Pediatric Oncology
- Articles
Type at least 3 characters
523 articles
Articles
Original Research
Published on 13 Oct 2023
Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1276175
- 1,522 views
- 4 citations
Original Research
Published on 10 Oct 2023
VRK3 depletion induces cell cycle arrest and metabolic reprogramming of pontine diffuse midline glioma - H3K27 altered cells
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1229312
- 2,371 views
Review
Published on 10 Oct 2023
Novel therapeutic approaches for pediatric diencephalic tumors: improving functional outcomes
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1178553
- 2,547 views
Original Research
Published on 10 Oct 2023
CritCom: assessment of quality of interdisciplinary communication around deterioration in pediatric oncologic patients
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1207578
- 2,085 views
Original Research
Published on 04 Oct 2023
Unraveling the impact of upfront chemotherapy and proton beam therapy on treatment outcome and follow-up in central nervous system germ cell tumors: a single center experience
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1259403
- 1,740 views
- 1 citation
Original Research
Published on 02 Oct 2023
Primary presentation and clinical course of pediatric and adolescent patients with differentiated thyroid carcinoma after radioiodine therapy
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1237472
- 1,014 views
Mini Review
Published on 26 Sep 2023
Hyperbaric oxygen therapy as a complementary treatment in neuroblastoma — a narrative review
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1254322
- 6,505 views
Original Research
Published on 21 Sep 2023
Prognostic factors and predictive scores for 6-months mortality of hematopoietic stem cell transplantation recipients admitted to the pediatric intensive care unit
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1161573
- 1,862 views
Original Research
Published on 19 Sep 2023
Ferroptosis regulator NOS2 is closely associated with the prognosis and cell malignant behaviors of hepatoblastoma: a bioinformatic and in vitro study
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1228199
- 3,487 views
- 1 citation
Review
Published on 13 Sep 2023
Bridging the age gap: a review of molecularly informed treatments for glioma in adolescents and young adults
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1254645
- 3,821 views
- 1 citation
Correction
Published on 08 Sep 2023
Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1282607
- 949 views
Original Research
Published on 04 Sep 2023
High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1237170
- 2,576 views
- 2 citations
Original Research
Published on 21 Aug 2023
Identifying central symptom clusters and correlates in children with acute leukemia undergoing chemotherapy: a network analysis
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1236129
- 2,442 views
- 6 citations
Review
Published on 18 Aug 2023
A review of the therapeutic potential of histone deacetylase inhibitors in rhabdomyosarcoma
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1244035
- 2,606 views
- 4 citations
Original Research
Published on 18 Aug 2023
Benefit of continuous kidney replacement therapy for managing tumor lysis syndrome in children with hematologic malignancies
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1234677
- 2,573 views
- 2 citations